Novel Therapies for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Alterations: A Spotlight on Capmatinib

Novel Therapies for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Alterations: A Spotlight on Capmatinib

Aaron C Tan,1 Tracy J Loh,2 Xue Lin Kwang,1 Gek San Tan,2 Kiat Hon Lim,2 Daniel SW Tan1 1Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore; 2Department of Pathology, Singapore General Hospital, Singapore, 169608, SingaporeCorrespondence: Daniel SW TanNation...

Full description

Bibliographic Details
Main Authors:	Tan AC, Loh TJ, Kwang XL, Tan GS, Lim KH, Tan DSW
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-03-01
Series:	Lung Cancer : Targets and Therapy
Subjects:	capmatinib met exon 14 skipping non-small cell lung cancer targeted therapy
Online Access:	https://www.dovepress.com/novel-therapies-for-metastatic-non-small-cell-lung-cancer-with-met-exo-peer-reviewed-article-LCTT

Similar Items

Interstitial lung disease associated with capmatinib therapy in a patient with non‐small cell lung cancer harboring a skipping mutation of MET exon 14
by: Hiroaki Kanemura, et al.
Published: (2021-02-01)

Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges
by: Fujino T, et al.
Published: (2021-05-01)

Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study
by: Li Liu, et al.
Published: (2021-06-01)

Mesenchymal-Epithelial Transition Exon 14 Skipping Mutation and Amplification in 5,008 Patients With Lung Cancer
by: Yaolin Song, et al.
Published: (2021-09-01)

Robust home brew fragment sizing assay for detection of MET exon 14 skipping mutation in non–small cell lung cancer patients in resource constrained community hospitals
by: Anurag Mehta, et al.
Published: (2021-09-01)

Cost-Efficient and Easy to Perform PCR-Based Assay to Identify Met Exon 14 Skipping in Formalin-Fixed Paraffin-Embedded (FFPE) Non-Small Cell Lung Cancer (NSCLC) Samples
by: Odharnaith O’Brien, et al.
Published: (2019-01-01)

MET Exon 14 Skipping: A Case Study for the Detection of Genetic Variants in Cancer Driver Genes by Deep Learning
by: Vladimir Nosi, et al.
Published: (2021-04-01)

Intracranial Activity of Osimertinib Plus Capmatinib in a Patient With EGFR and MET-Driven Lung Cancer: Case Report
by: Oliver Gautschi, MD, et al.
Published: (2021-04-01)

Lazarus Response to Tepotinib for Leptomeningeal Metastases in a Patient With MET Exon 14 Skipping Mutation–Positive Lung Adenocarcinoma: Case Report
by: Taira Ninomaru, MD, et al.
Published: (2021-03-01)

Therapeutic strategies in METex14 skipping mutated non-small cell lung cancer
by: Leylah M. Drusbosky, et al.
Published: (2021-08-01)

Efficacy of pembrolizumab for patients with both high PD‐L1 expression and an MET exon 14 skipping mutation: A case report
by: Keisuke Baba, et al.
Published: (2019-02-01)

Rapid Disease Progression in a Patient with Advanced NSCLC Harboring a Germline MET Exon 14 Skipping Mutation: A Case Report
by: Jiao Y, et al.
Published: (2021-04-01)

Incidence and PD-L1 Expression of MET 14 Skipping in Chinese Population: A Non-Selective NSCLC Cohort Study Using RNA-Based Sequencing
by: Xu Z, et al.
Published: (2020-06-01)

Polypurine Reverse-Hoogsteen Hairpins as a Tool for Exon Skipping at the Genomic Level in Mammalian Cells
by: Véronique Noé, et al.
Published: (2021-04-01)

Non‐small cell lung cancer with mesenchymal–epithelial transition gene exon 14 skipping mutation treated with crizotinib
by: Seigo Katakura, et al.
Published: (2019-10-01)

Targeting the MET-Signaling Pathway in Non-Small–Cell Lung Cancer: Evidence to Date
by: Bylicki O, et al.
Published: (2020-06-01)

Exon skipping-rich transcriptomes of animals reflect the significance of exon-shuffling in metazoan proteome evolution
by: Laszlo Patthy
Published: (2019-01-01)

CRISPR-induced exon skipping is dependent on premature termination codon mutations
by: Tingting Sui, et al.
Published: (2018-10-01)

Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
by: Kane L Greer, et al.
Published: (2014-01-01)

Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges
by: Yusuke Echigoya, et al.
Published: (2018-12-01)

Classifying Included and Excluded Exons in Exon Skipping Event Using Histone Modifications
by: Wei Chen, et al.
Published: (2018-10-01)

Polyquaternium-mediated delivery of morpholino oligonucleotides for exon-skipping in vitro and in mdx mice
by: Mingxing Wang, et al.
Published: (2017-01-01)

Synthesis of a Morpholino Nucleic Acid (MNA)-Uridine Phosphoramidite, and Exon Skipping Using MNA/2′-O-Methyl Mixmer Antisense Oligonucleotide
by: Suxiang Chen, et al.
Published: (2016-11-01)

<i>APC</i> Splicing Mutations Leading to In-Frame Exon 12 or Exon 13 Skipping Are Rare Events in FAP Pathogenesis and Define the Clinical Outcome
by: Vittoria Disciglio, et al.
Published: (2021-02-01)

Analysis and Prediction of Exon Skipping Events from RNA-Seq with Sequence Information Using Rotation Forest
by: Xiuquan Du, et al.
Published: (2017-12-01)

Single Exon Skipping Can Address a Multi-Exon Duplication in the Dystrophin Gene
by: Kane Greer, et al.
Published: (2020-06-01)

Six Exonic Variants in the SLC5A2 Gene Cause Exon Skipping in a Minigene Assay
by: Sai Wang, et al.
Published: (2020-11-01)

Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities
by: Jamie L. Grit, et al.
Published: (2020-03-01)

Endogenous Multiple Exon Skipping and Back-Splicing at the DMD Mutation Hotspot
by: Hitoshi Suzuki, et al.
Published: (2016-10-01)

Identification of exon skipping events associated with Alzheimer’s disease in the human hippocampus
by: Seonggyun Han, et al.
Published: (2019-01-01)

Repurposing Dantrolene for Long-Term Combination Therapy to Potentiate Antisense-Mediated DMD Exon Skipping in the mdx Mouse
by: Derek W. Wang, et al.
Published: (2018-06-01)

Reverse complementary matches simultaneously promote both back-splicing and exon-skipping
by: Dong Cao
Published: (2021-08-01)

Proof-of-Concept: Antisense Oligonucleotide Mediated Skipping of Fibrillin-1 Exon 52
by: Jessica M. Cale, et al.
Published: (2021-03-01)

RNA Secondary Structure-Based Design of Antisense Peptide Nucleic Acids for Modulating Disease-Associated Aberrant Tau Pre-mRNA Alternative Splicing
by: Alan Ann Lerk Ong, et al.
Published: (2019-08-01)

Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency
by: HaiFang Yin, et al.
Published: (2013-01-01)

Saponins enhance exon skipping of 2′-O-methyl phosphorothioate oligonucleotide in vitro and in vivo
by: Wang M, et al.
Published: (2018-10-01)

Predicting exon criticality from protein sequence
by: Desai, J., et al.
Published: (2022)

Novel Cationic Carotenoid Lipids as Delivery Vectors of Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy
by: Vassilia Partali, et al.
Published: (2012-01-01)

Rescue of a dystrophin-like protein by exon skipping normalizes synaptic plasticity in the hippocampus of the mdx mouse
by: Glenn Dallérac, et al.
Published: (2011-09-01)

A Novel Homozygous VPS13B Splice-Site Mutation Causing the Skipping of Exon 38 in a Chinese Family With Cohen Syndrome
by: Liangshan Li, et al.
Published: (2021-04-01)